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Abstract 
 
In the present work, we purified and characterized a novel toxin named hemicalcin from the 
venom of the Iranian chactoid scorpion Hemiscorpus lepturus where it represents 0.6% of the 
total protein content. It is a 33-mer basic peptide reticulated by three disulfide bridges, and that 
shares between 85 and 91% sequence identity with four other toxins, all known or supposed to be 
active on ryanodine-sensitive calcium channels. Hemicalcin differs from these other toxins by 
seven amino acids at positions 9 (L/R), 12 (A/E), 13 (D/N), 14 (K/N), 18 (S/G), 26 (T/A) and 28 
(P/I/A). In spite of these differences, hemicalcin remains active on ryanodine-sensitive Ca
2+
 
channels, since it increases [
3
H]-ryanodine binding on RyR1 and triggers Ca
2+
 release from 
sarcoplasmic vesicles. Bilayer lipid membrane experiments, in which the RyR1 channel is 
reconstituted and its gating properties analyzed, indicate that hemicalcin promotes an increase in 
the opening probability at intermediate concentration and induces a long-lasting subconductance 
level of 38% of the original amplitude at higher concentrations. Mice intracerebroventricular 
inoculation of 300 ng hemicalcin induces neurotoxic symptoms in vivo, followed by death. 
Overall, these data identify a new biologically active toxin that belongs to a family of peptides 
active on the ryanodine-sensitive channel. 
 
 
Running title: Hemicalcin, a toxin active on ryanodine receptor 
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Abbreviations 
 
BLM: bilayer lipid membrane - CNS: central nervous system - DHPR : dihydropyridine receptor 
- HL: Hemiscorpius lepturus - ICK: inhibitor cystine knot – IpTx A: imperatoxin A – JSR: 
junctional sarcoplasmic reticulum - RyR1: ryanodine receptor type 1 - SR: sarcoplasmic 
reticulum – TFA, trifluoroacetic acid 
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Introduction 
Hemiscorpius Lepturus (HL) is the most dangerous scorpion of Khuzestan, the south-west, hot 
and humid province of Iran. Ten to 15% of total scorpion stings during the hot season and almost 
all cases of scorpion stings during winter are due to Hemisorpius lepturus. These observations are 
based on a sample of 2534 patients who brought a scorpion specimen to a medical centre while 
seeking treatment [1]. In addition to inducing typical symptoms of necrosis and ulceration of the 
skin and haemolysis of blood cells, HL venom exerts its most toxic effects on the central nervous 
(CNS) and cardiovascular systems [1]. Scorpion peptides that possess a neurotoxic activity in 
mice are generally known to modulate Na
+
, K
+
 or Ca
2+
 channels. Calcium channels have been 
classified into various subfamilies including voltage-gated channels, voltage-independent 
channels and intracellular endoplasmic/sarcoplasmic reticulum calcium release channels. The 
latter channels include the ryanodine receptors (RyRs) whose openings can be induced by Ca
2+
 
itself or by an allosteric coupling with the plasmalemmal dihydropyridine receptor (DHPR) [2,3]. 
Only a few scorpion venom peptides have been identified to possess activity towards ryanodine 
receptors. Pandinus imperator venom contains imperatoxin I and imperatoxin A (IpTx I and A; 
[4,5]), whereas Scorpio maurus contains maurocalcine (MCa; [6]), Buthus martensii Karsch 
contains BmK-PL toxin [7], and Buthotus judaicus contains BjTx-1 and BjTx-2 [8]. Although 
these toxins are potent modulators of RyRs, they are structurally divergent. BjTx-1 and BjTx-2 
adopt a classical α/β scaffold as many toxins active on voltage-gated K+ and Na+ channels [9,10], 
whereas MCa and IpTx A are the only scorpion toxins that adopt an inhibitor cystine knot (ICK) 
fold [11,12]. In the present work, we isolated, identified and characterized a new neurotoxic 
peptide from the Iranian scorpion Hemiscorpius lepturus. This toxin, named hemicalcin (HCa), 
differs from MCa and IpTx A by three and four amino acids, respectively. Hemicalcin stimulates 
[
3
H]-ryanodine binding to type 1 RyR (RyR1), produces Ca
2+
 release from sarcoplasmic 
reticulum (SR) vesicles, and triggers significant changes in the biophysical behaviour of RyR1 
channels reconstituted in bilayer lipid membranes. Compared to MCa, hemicalcin is significantly 
more toxic to mice in vivo. The data presented herein indicates that hemicalcin represents a new 
member of the small family of toxins active on RyR1.  
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Experimental 
 
Scorpion venom  
Venoms of Hemiscorpius lepturus scorpions from Khuzestan (Iran) were collected by the 
veterinarian service of the RAZI Vaccine Development and Serum Research Institute of Iran and 
kept frozen at -20°C in their crude forms until use.  
 
Purification of hemicalcin 
Crude venoms were dissolved in water and loaded on Sephadex G-50 gel filtration 
chromatography columns (2 x K26/50) to isolate a neurotoxic fraction. The columns were 
equilibrated with 20 mM ammonium acetate at pH 4.7. The neurotoxic fraction was identified by 
intracereboventricular (ICV) injection in mice. After lyophilization, the neurotoxic fraction was 
fractionated by HPLC using a C8 reversed-phase HPLC column (5 µm, 4.6 x 250 mm, Beckman 
Fullerton, CA, USA), equipped with a Beckman Series 125 pump and a Beckman diode array 
detector set at 214 nm and 280 nm. Elution was controlled by means of the software GOLD. 
Proteins were eluted from the column at a flow rate of 0.8 ml/min using a linear gradient (45 min) 
from 12 to 40 % of solution B [0.1 % TFA (trifluoroacetic acid) in acetonitrile] in solution A (0.1 
% TFA in water). The protein concentration was measured by the Bradford method. 
 
In vivo toxicity tests and LD
50
 determination 
The in vivo toxicity of hemicalcin was tested on 20 ± 2 g C57/BL6 male mice by 
intracerebroventricular (ICV) injection of 5 µl of 0.1% (w/v) BSA solutions containing 
increasing amounts of the polypeptides. Six mice were used for each dose; two control mice were 
injected with only 0.1% BSA in water to be sure that symptoms are not due to experimental 
conditions. ICV administration was performed under anaesthesia, according to the method 
described by Galeotti et al [13]. 
 
Amino acid sequence determination of hemicalcin 
Reduction of hemicalcin with dithiothreitol, and alkylation with 4-vinylpyridine, were performed 
as previously described [14]. The sequence of reduced/carboxymethylated toxin was determined 
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using an automatic liquid-phase protein sequencer (model 476A, Applied Biosystems) using a 
standard Edman protein degradation. Hemicalcin was deposited onto Biobrene-precycled glass-
fibre discs.  
 
Mass spectrometry 
Samples were analyzed on Voyager-DE
TM
 PRO MALDI-TOF Workstation mass spectrometer 
(Perseptive Biosystems, Inc., Framingham, MA). The peptide was dissolved in CH
3
CN/H
2
O 
(30/70) with 0.3% TFA to obtain a concentration of 1-10 pmol/µl. The matrix was prepared as 
follows: alpha-cyanohydroxycinnamic acid was dissolved in 50% CH
3
CN in 0.3% TFA/H
2
O to 
obtain a saturated solution of 10 µg/µl. 0.5 µl of peptide solution was mixed with 0.5 µl of matrix 
solution, placed on the sample plate and the mixture was allowed to dry. Mass spectra were 
recorded in reflectron mode after external calibration with suitable standards and were analysed 
using the GRAMS/386 software. 
 
Sequence comparison 
Peptides showing sequence similarity with hemicalcin were identified with BLAST2 [15] in the 
non redundant database. Best hits were calcium channel toxin modulators. The amino acid 
sequences of these peptides were aligned and identities determined. 
 
SR vesicles preparation 
Heavy SR vesicles were prepared following a modified method of Kim and collaborators [16] as 
described in Marty et al. [17]. Junctional SR was prepared as described by Pessah et al. [18]. 
Protein concentration was measured by the methods of Biuret or Lowry. 
 
[
3
H]-ryanodine binding assay 
Heavy SR vesicles (1 mg/ml) were incubated at 37°C for 3 hrs in an assay buffer composed of 5 
nM [
3
H]-ryanodine, 150 mM NaCl, 2 mM EGTA, 2 mM CaCl
2
 (pCa=5), and 20 mM HEPES, pH 
7.4. Hemicalcin was added to the assay buffer just prior the addition of heavy SR vesicles. [
3
H]-
ryanodine bound to heavy SR vesicles was measured by filtration through Whatmann GF/B glass 
filters followed by three washes with 5 ml of ice-cold washing buffer composed of 150 mM 
NaCl, 20 mM HEPES, pH 7.4. Filters were then soaked overnight in 10 ml scintillation cocktail 
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(Cybscint, ICN) and bound radioactivity determined by scintillation spectrometry. Non-specific 
binding was measured in the presence of 20 µM unlabelled ryanodine. Each experiment was 
performed in triplicate and repeated at least two times. All data are presented as mean ± S.D. 
 
Ca
2+
 release measurements 
Ca
2+
 release from heavy SR vesicles was measured using antipyrylazo III, a Ca
2+
-sensitive dye.  
The absorbance was monitored at 710 nm by a diode array spectrophotometer (MOS-200 Optical 
System, Biologic, Claix, France). 25 µg of heavy SR vesicles were actively loaded with Ca
2+
 at 
37°C in a 2 ml buffer containing: 100 mM KCl, 7.5 mM sodium pyrophosphate, 20 mM 
potassium 3-(N-morpholino)propanesulfonic acid (MOPS), pH 7.0, supplemented with 250 µM 
antipyrylazo III and 1 mM ATP/MgCl
2
. Ca
2+
 loading was started by four sequential additions of 
20 µM CaCl
2
. In these loading conditions, there was no calcium-induced calcium release to 
interfere with the effect of hemicalcin on Ca
2+
 release from heavy SR vesicles. At the end of the 
experiment, the Ca
2+
 released by hemicalcin was chelated by the addition of 1 mM EGTA. 
 
Recording and analysis of RyR1 single channel activity in bilayer lipid membrane (BLM) 
The BLM was formed across a 200 µm aperture drilled into a polysulfone cup (Warner 
Instrument Corp., CT) using a mixture composed of phosphatidylethanolamine: 
phosphatidylserine: phosphatidylcholine (5:3:2 w/w, Avanti Polar Lipids, Inc, AL) dissolved in 
decane at a final concentration of 30 mg/ml. The BLM partitioned two chambers (cis and trans) 
with buffer solution (in mM): 500 CsCl, 7 µM free Ca2+, and 20 HEPES-Tris (pH 7.4) on cis, 50 
CsCl and 20 HEPES-Tris (pH 7.4) on trans. The cis chamber was virtually grounded, whereas 
the trans chamber was connected to the head stage input of an amplifier (Bilayer Clamp BC 
525C, Warner Instrument, CT). Single channels were obtained by introducing rabbit skeletal 
muscle junctional SR (JSR) vesicles or purified RyR1 preparation in the cis chamber to induce 
fusion with the BLM. Immediately after incorporation of a channel into the BLM, the cis 
chamber was perfused with an identical solution to prevent additional vesicle fusions. Single 
channel gating was monitored and recorded at a holding potential of -40 mV (applied to the trans 
side). The amplified current signals, filtered at 1 kHz (8 Pole Low-Pass Bessel Filter, Warner 
Instrument, CT) was digitized and acquired at a sampling rate of 10 kHz (Digidata 1320A, Axon-
Molecular Devices, Union City, CA). All the recordings were made for at least 3 min under each 
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defined condition. The channel open probability (P
o
), mean open-, mean closed-dwell times (τ
o
 
and τ
c
) and current amplitude histograms were calculated and graphically displayed using 
Clampfit, pClamp software 9.0 (Axon-Molecular Devices, Union City, CA). 
 
Molecular modelling  
A structural model of hemicalcin was generated by homology modelling with the program 
Modeller 8v2 [19]. Homologous polypeptides with known structures were identified by a Blast2 
[15] search of the PDB database (RCSB organization) using the sequence of hemicalcin as entry. 
The solution structure of MCa (PDB code 1C6W) [11] and IpTx A (PDB code 1IE6) [12] were 
used as templates. Twenty structures were calculated, from which only one model, combining the 
best Ramachandran plot (http://swift.cmbi.kun.nl/WIWWWI/ramaplot.html; [20]), and good 
scores for the objective function values [19], and the VICTOR/FRST energy function proposed 
by Tossato (2005) (http://protein.cribi.unipd.it/frst/; [21]), was selected. The model was then 
visualized with the ViewerLite50 program (http://www.accelrys.com/products/dstudio/). 
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RESULTS 
 
Purification of hemicalcin 
After Sephadex G50-chromatography of the  Hemiscorpius lepturus venom, each fraction 
obtained was injected to the mice by ICV route and the neurotoxic fractions were pooled (Figure 
1A) and applied to a C8 HPLC column. Hemicalcin was eluted at 18.93 min (Figure 1B). An 
analytical HPLC run of hemicalcin showed a single symmetric peak. Hemicalcin represents about 
0.6% of the Hemiscorpius lepturus venom.  
 
In vivo toxicity of hemicalcin 
Hemicalcin (500 ng in 5 µl) was injected into mice using the ICV route and the following 
symptoms were observed. The toxin produced rapid paralysis in the lower half of the body. The 
mice are no longer able to move their head forward. The mice turn backward while moving 
circularly, and their head are down to the ground and bent to the body. Five to ten minutes after 
injection, the first symptoms disappear and the mice start to jump and run very fast. This 
phenomenon takes 1 to 2 min. The animals then stop moving and start trembling for a while. 
Next, they take a rest without any movement. Jumping, running and trembling happens every 5 to 
10 min. The last stage is repeated 4 to 5 times and in the last trembling episode, spasms occur in 
all muscles and the animals die while their bodies are laid down and their four legs are in a 
straight position. With sublethal doses of hemicalcin, the same symptoms were observed except 
the very last stage that precedes death. The 50% killing dose for mice is of 300 ng, giving an 
LD50 of 15 µg toxin/ 1 Kg mouse. 
 
Sequence determination and comparison to other scorpion toxins 
Edman degradation of 2 nmoles of S-pyridyl-ethylated peptides led to the identification of the 
complete amino acid sequence of the peptide (Figure 2). Hemicalcin is a peptide composed of 33 
amino acid residues containing six cysteine residues. The experimental molecular mass of native 
hemicalcin (3788.09 ± 0.67 Da) obtained by MALDI is nearly identical to the average theoretical 
molecular mass calculated for the fully oxidized form of hemicalcin (3787 Da). These results 
indicate that the six cysteines of hemicalcin are engaged in three intramolecular disulfide bridges. 
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Moreover, only a monomeric form was observed in the mass spectra, suggesting the absence of 
intermolecular disulfide bridges.  
Hemicalcin has very strong sequence homologies with MCa from the chactoid scorpion Scorpio 
maurus [6] (91% sequence identity), with IpTx A from the scorpion Pandinus imperator [5] 
(88% sequence identity), and with both opicalcine 1 and 2 from the scorpion Opistophthalmus 
carinatus [22] (88% and 85% sequence identity, respectively) (Figure 2). Among these toxins, 
variation in amino acid sequence takes place at seven positions (9, 12-14, 18, 26, and 28) without 
altering the net global charge of the peptides (+8). The alignment of the cysteine residues of 
hemicalcin with that of MCa and IpTx A, indicates that hemicalcin could also possess the typical 
pairing of disulfide bridges observed in the family of toxins belonging to the family scorpionidae 
(Cys3-Cys17, Cys10-Cys21, and Cys16-Cys32). 
Like the four other scorpion toxins, hemicalcin also presents a sequence homology (21 % 
identity) with peptide A which is derived from the cytoplasmic II-III loop of the Ca
v
1.1 subunit 
of the DHPR (Figure 2B).  
 
[
3
H]-ryanodine binding assay  
MCa and IpTx A are both known to stimulate the binding of [
3
H]-ryanodine, a biochemical 
indicator of channel activity, to heavy SR vesicles enriched in RyR1 [5,11]. Considering the 
sequence homology among these toxins, it is expected that hemicalcin should also enhance [
3
H]-
ryanodine binding onto RyR1. Figure 3 demonstrates that hemicalcin does indeed increase the 
binding of [
3
H]-ryanodine in a dose-dependent manner with an EC
50
 of 71 ± 6 nM. Under these 
assay conditions, the binding of [
3
H]-ryanodine on RyR1 was stimulated by 11.8 fold at 
saturating concentrations of hemicalcin. By comparison, MCa was slightly more effective than 
hemicalcin since it increased [
3
H]-ryanodine binding by 16.7-fold with an EC
50
 of 25 ± 2 nM. 
 
Enhancement of Ca
2+
 release from SR 
In order to investigate the effect of hemicalcin on Ca
2+
 release from heavy SR vesicles, we first 
determined that the purified hemicalcin did not contain any significant Ca
2+
 concentration that 
could affect the interpretation of Ca
2+
 release measurements induced by the peptide. Absorbance 
measurements indeed illustrate the absence of significant Ca
2+
 concentration upon addition of 40 
nM hemicalcin (Fig. 4A). Next, we actively loaded the SR vesicles by four consecutive additions 
Mis en forme : Exposant
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of Ca
2+
 (20 µM) in the presence of ATP-Mg
2+
, pyrophosphate and ATP regenerating system. 
After Ca
2+
 loading reaches equilibrium, addition of 125 nM hemicalcin along with 20 µM Ca
2+
 to 
the external medium induces Ca
2+
 release as shown in Figure 4B. The hemicalcin response comes 
with a slower up rise kinetics than the added Ca
2+
 again indicating that could not be linked to 
contaminating Ca
2+
 from the purified material. External Ca
2+
 level reaches a plateau level 
indicating that near maximal Ca
2+
 release had occurred. Ca
2+
 was added along hemicalcin as it 
appears to promote the effect of the peptide. The remaining Ca
2+
 from the SR vesicles could be 
released by the application of 1 µM A23187 ionophore. Further application of 20 µM external 
Ca
2+
 were not taken up by the vesicles, coherent with the effect of the ionophore in SR vesicles, 
which is to produce a continuous Ca
2+
 leakage from the vesicles. The external Ca
2+
 concentration 
can be lowered by the application of 0.5 mM external EGTA. The Ca
2+
 specifically released by 
hemicalcin from the SR vesicles amounted to 47.7 ± 15.1 nmol (n=3) and represented 66 ± 18% 
of the total calcium stored by the vesicles. As control experiments, and in order to make sure that 
the fifth application of 20 µM Ca
2+
 is not responsible for the large response of hemicalcin, an 
experiment was performed in which five consecutive application of 20 µM Ca
2+
 were applied to 
SR vesicles (Figure 4C). As indicated, 20 µM Ca
2+
 alone for the fifth application does not 
produce a response similar than 20 µM Ca
2+
 along with hemicalcin. This was also not the case 
when the fifth application was 40 µM Ca
2+
, totally precluding the idea that hemicalcin is 
contaminated with calcium. Overall, these results are similar to those previously observed with 
MCa and imperatoxin A indicating a possible direct effect of hemicalcin on RyR1 [23, 24]. To 
further illustrate this point, the effect of hemicalcin on RyR1 channel activity was investigated. 
 
Effects of hemicalcin on RyR1 channel activity 
The mechanism by which hemicalcin influences RyR1 channel activity was further assessed by 
measuring the effects of the toxin on the gating parameters of single channels reconstituted into 
BLM. Figure 5 shows a RyR1 channel in the presence of 7 µM cytosolic Ca2+ before (Panel A) 
and after (Panels B & C) being exposed to nanomolar concentrations of hemicalcin. In the 
absence of hemicalcin, the channel exhibited low activity with an open probability (Po) of 0.039 
(Panel A). However, addition of 175 nM hemicalcin into cis solution rapidly activated the 
channel, promoting a 2.1-fold increase of the Po to 0.083 and moderate changes in both the mean 
open-, closed-dwell time values (τ
o
 and τ
c
): τ
o
 increased by 124% whereas τ
c
 decreased by 59%. 
Mis en forme : Exposant
Mis en forme : Exposant
Mis en forme : Exposant
Mis en forme : Exposant
Mis en forme : Exposant
Mis en forme : Exposant
Mis en forme : Exposant
Mis en forme : Exposant
Mis en forme : Exposant
Mis en forme : Exposant
Supprimé : 250 
Supprimé : occured
Supprimé : T
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A prominent effect of hemicalcin (175 nM) on channel gating behaviour was stabilization of an 
occasional long-lasting sub-conductance state. Amplitude histogram analysis indicates that the 
predominant hemicalcin-modified sub-conductance state was ~38 % of the full state of 37.2 pA. 
The hemicalcin-modified channel displayed a mean open time of τ
o 
= 0.92 ± 0.32 sec, more than 
1600-fold longer than that of the native RyR1 channel gating mode. The occurrence (F
o
) of this 
sub-conductance gating is ~2.7 % (the percentage of the time that the channel gates in a sub-
conductance state versus total time, all-mode gating states). A higher concentration of hemicalcin 
(350 nM final concentration in cis solution, Panel C) did not further significantly change the Po, 
τ
o
 and τ
c
, but resulted in more frequent appearance of the long-lasting sub-conductance gating 
mode: F
o
 increased more than 4-fold from 2.7 % to 11.1 %. The subsequent addition of ryanodine 
(125 µM) into the cis solution of the hemicalcin-modified channel, rapidly stabilized a sub-state 
approximately 60 % of the full conductance state (ryanodine-modified substate), with frequent 
closures to a current level 20.9 % of the maximum current level (ryanodine + hemicalcin-
modified state). Under these conditions, the channel shut down completely within 45 sec (data 
not shown). 
In other BLM experiments, 50 nM hemicalcin was found to produce negligible effect on 
RyR1 channel gating kinetics (n=3); whereas at 100 nM the toxin slightly increased Po and 
induced the occasional appearance of long-lasting sub-conductance gating mode indicating that 
the effects of hemicalcin on channel gating are dose-dependent (data not shown).  
 
Molecular model of hemicalcin 
The molecular model of hemicalcin was established by homology modelling using solution 
structures of MCa and IpTx A as templates. The molecular model of hemicalcin is shown along 
the 3-D solution structure of MCa (Figure 6A). As expected, the fold of the HCa model appears 
to be very similar to the folding of the template experimental structure : i.e. a compact disulfide-
bonded core from which several loops and the N-terminus emerge. The main elements of regular 
secondary structure are a double-stranded antiparallel β-sheet comprising residues 20-22 and 30-
33, a third peripheral extended strand composed of residues 8-10, which is almost perpendicular 
to the double-stranded antiparallel β-sheet, and a helical turn composed of residues 13-15. Thus, 
the model suggests that hemicalcin probably folds according to the inhibitor cystine knot (ICK) 
previously described in MCa [11] and IpTx A [12]. 
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Discussion 
 
In this study, we isolated the first toxin from the venom of the Iranian scorpion Hemiscorpus 
lepturus, herein termed hemicalcin. It is a highly basic 33 amino acid residue peptide that is 
cross-linked by three disulfide bridges. It shares about 90% sequence identity with MCa and 88% 
with IpTx A. Like these two related toxins, hemicalcin also shares sequence homology with 
peptide A, a domain of the II-III loop of Ca
v
1.1, a dihydropyridine-sensitive voltage-dependent 
calcium channel of the skeletal muscle. A common binding site on RyR1 that can bind peptide A 
as well as MCa indicates that the binding of these toxins on RyR1 involves the region of 
homology between peptide A and the toxins [25]. Peptide A induces Ca
2+
 release from SR and 
enhances current flow through RyR1 channels [5,26-28]. The ability of peptide A to activate 
RyR1 is highly related on the orientation of its positively charged residues along one face of the 
molecule [28]. Both IpTx A and MCa also share a similar orientation of positively charged 
residues with peptide A in this surface [11,28], indicating that a same basic domain at the surface 
of these peptides is most likely involved in the activation of the RyR1 channel. The molecular 
model of hemicalcin suggests that it also possesses a highly basic domain that presents the same 
surface orientation as in IpTx A and MCa. Because of its high homology with peptides active on 
RyR1 channels, we expected that hemicalcin could be able to activate this channel type too. 
Indeed, hemicalcin was found to increase [
3
H]-ryanodine binding on RyR1 with an apparent EC
50
 
of 71 ± 6 nM. In comparison, hemicalcin was found almost as potent as MCa for stimulating 
[
3
H]-ryanodine binding. Also, application of 50 nM hemicalcin on SR-loaded with Ca
2+
 produced 
a significant Ca
2+
 release. Enhanced release of Ca
2+
 and specific [
3
H]-ryanodine binding is due to 
a direct effect of hemicalcin on the gating properties of RyR1 channel since the peptide induces 
an increase in opening probability and, at higher concentrations, stabilizes a long-lived sub-
conductance state. These results show that the activity of hemicalcin on RyR1 Ca
2+
 channels is 
similar to those observed with the two other toxins characterized hitherto, indicating that these 
toxins have similar mechanisms of action on RyR1. However, the predominant sub-conductance 
level that hemicalcin induces (38% of full conductance) differs significantly from those measured 
with MCa (~48-54% of full conductance; [23,24]) or IpTx A (25% of full conductance; [29,30]). 
The functional differences observed among these toxins must be endowed by their structural 
differences. 
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Structure-function relationships of calcium channel scorpion toxins, especially on RyR isoforms 
specificity, are not yet well defined because only few members of these toxins were found within 
a scorpion specie. Until now only two toxins MCa and IptxA (from scorpio maurus and Pandinus 
Imperator scorpions, respectively) derived from orthologous genes, were studied.  The discovery 
of new natural toxins from related species might give access to active structures displaying 
multipoint mutations compared with these two toxins and may bring useful information in 
structure-function relationships. Previous study on synthetic monosubstituted analogues of MCa, 
showed that some amino acid residues of MCa can be classified in three different groups : (i) 
residues belonging to the basic class that are important for interaction with RyR1 (Lys
22
, Arg
23
 
and Arg
24
); (ii) residues belonging or not to the basic class that appear less important for the 
interaction with RyR1 (Lys
19
, Lys
20
 and Thr
26
); and (iii) a residue of the acidic face that appears 
to mildly affect the interaction with RyR1 (Lys
8
) [23]. All these residues are conserved in 
hemicalcin; only 3 amino acids are different between hemicalcin and MCa (A
12
/E
12
, D
13
/N
13
 and 
P
28
/I
28
), whereas 4 differences are noted between hemicalcin and imperatoxin A (L
9
/R
9
, K
14
/N
14
, 
S
18
/G
18
 and P
28
/A
28
). Compared to the MCa experimental structure, the molecular model of 
hemicalcin suggestes that the A
12
/E
12
, D
13
/N
13
 and P
28
/I
28
 mutations have no significant effect on 
the backbone structure. Careful examination of the side-chains of these residues showed that D
13
 
likely interacts with five Lys residues (K
14
, K
19
, K
20
, K
22
, and K
30
) in HCa. The interaction 
between D13 and K30 may be especially privileged, thus allowing K
14 
to be well exposed. In 
IpTx A, D
13
 interacts with only four Lys residues (K
19
, K
20
, K
22
, and K
30
), whereas in MCa, E
12,
 
which does not possess a homologous, but rather an adjacent relative (D13) in HCa, interacts also 
with four Lys residues (K
14
, K
11
, K
19
, and K
30
). Although the net global charge of MCa and Iptx 
A is conserved in HCa, a double mutation in the 9-14 region (D
13
/N
13
 and A
12
/E
12,
 L
9
/R
9
 and 
K
14
/N
14
) may change its electrostatic environment. This property may explain the fact that 
hemicalcin exhibits a lower potency on RyR1 compared to MCa and IpTx A. 
The differences in toxicity of hemicalcin and of the two related toxins are also interesting to note. 
According to their respective LD
50
, hemicalcin (LD
50
 = 15 µg toxin/1 Kg mouse) is 67 times 
more toxic on mice than MCa (LD
50 
= 400 µg toxin/1 Kg mouse [6]) by intracerebroventricular 
inoculation. The neurotoxic symptoms observed in mice suggest that hemicalcin is active on the 
CNS, but this requires further investigations. Among different hypothesis that may explain these 
differences, one suggests that hemicalcin is more resistant to proteolysis, more efficient in terms 
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of cell penetration to reach its pharmacological target, or possibly more potent on related RyR 
isoforms, such as RyR3 or RyR2 that are predominantly expressed in the CNS. 
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Figures 
 
Figure 1. Purification of hemicalcin from the venom of Hemiscorpius lepturus 
A) The extracted venom was fractionated by G-50 gel filtration chromatography columns (2 x 
K26/50) equilibrated with 20 mM ammonium acetate pH 4.7. 
B) Hemicalcin was purified from the neurotoxic fraction (II’) by RP-HPLC on a C8 column using 
a gradient of buffer B (0.1% TFA in acetonitrile) as described in the Experimental section. 
Hemicalcin was collected at 18.93 min. 
 
 
Figure 2. Sequence alignment of hemicalcin with related toxins active on the ryanodine 
receptor 
A) Sequence alignment of hemicalcin with four analogous toxins, MCa, IpTx A, opicalcine 1 and 
opicalcine 2. MCa and IpTx A are two peptides known to be active on the ryanodine receptor. 
Opicalcine 1 and 2 have not been tested for pharmacological activity. All five toxins have the 
same number of positively charged amino acid residues (the N-terminal glycine residue, six or 
seven lysine residues, and five or four arginine residues; indicated in blue). Negatively charged 
amino acids are represented in red. 
B) A sequence alignment of hemicalcin with peptide A of the II-III loop of Ca
v
α
1.1
 subunit from 
the dihydropyridine receptor (DHPR) is also provided. The strongest homology stretches from 
Lys
19
 to Thr
26
 of hemicalcin. 
 
Figure 3. Hemicalcin affects [
3
H]-ryanodine binding on heavy SR vesicles 
Dose-dependent effect of hemicalcin on [
3
H]-ryanodine binding onto heavy SR vesicles (open 
circles). [
3
H]-ryanodine binding was measured at pCa 5 in the presence of 5 nM [
3
H]-ryanodine 
for 3 hrs at 37°C.  Non-specific binding remained constant at all hemicalcin concentrations and 
was less than 200 fmol/mg. Data were fitted with a logistic function y = y
0
 + (a / (1 + (x/EC
50
)
b
)) 
where y
0
 = 316 ± 46 in the absence of hemicalcin, a = 2799 ± 118 fmol/mg is the maximum [3H]-
ryanodine binding, b = -1.1 ± 0.1 the slope coefficient, and EC
50
 = 71 ± 6 nM the concentration 
of hemicalcin for half stimulation of [
3
H]-ryanodine binding. Overall, hemicalcin stimulates [
3
H]-
ryanodine binding by a factor of 11.8-fold at saturation level. For comparison, the data are also 
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shown for MCa (filled circles; y
0
 = 364 ± 129, a = 3502 ± 127 fmol/mg, b = -1.0 ± 0.1, and EC
50
 
= 25 ± 2 nM. Stimulation factor of 16.7 at saturation). 
 
Figure 4. Ca
2+
 release from heavy SR vesicles induced by hemicalcin 
A) Absorbance measured in the absence of SR vesicles and in response to sequential Ca
2+
 
additions in the medium or to 40 nM hemicalcin addition. The data indicate the lack of Ca
2+
 
presence in the purified material. 
B) Heavy SR vesicles were actively loaded with Ca
2+
 by four sequential additions of 20 µM 
CaCl
2
 in the monitoring chamber. The absorbance was monitored to show that the added Ca
2+
 
was taken up by the SR vesicles. The trace relaxed close to its original baseline with CaCl
2
 
additions constituting approximately 70-80% of the SR loading capacity. These Ca
2+
 additions 
were used to calibrate the Ca
2+
 release. Addition of 125 nM hemicalcin produces a long lasting 
Ca
2+
 release from SR vesicles. 20 µM Ca
2+
 was added along hemicalcin to control the 
extravesicular concentration of Ca
2+
. Also, external Ca
2+
 appears to act as a cofactor to 
hemicalcin effect. Residual Ca
2+
 from SR vesicles is released by the addition of 1 µM of the 
ionophore A23187. Further addition of 0.5 mM EGTA buffers the released and the basal Ca
2+
 
from the system. 
C) Loading of heavy SR vesicles with Ca
2+
 by five sequential additions of 20 µM CaCl
2
 in the 
monitoring absorbance chamber. The fifth application does not produce a similar calcium release 
as the one observed by the co-application of 20 µM Ca
2+
 and 125 nM hemicalcin in B). 
D) Loading of heavy SR vesicles with Ca
2+
 by four sequential additions of 20 µM CaCl
2
 and a 
fifth one at 40 µM in the monitoring absorbance chamber. The fifth application produces a slower 
loading of the vesicles but no sustained response. 
 
Figure 5. Hemicalcin alters gating kinetics and stabilizes subconductances of RyR1 single 
channel activity in bilayer lipid membrane 
RyR1 single channel was incorporated by inducing fusion of skeletal muscle junctional SR 
vesicles into BLM. The channel activities were recorded and analyzed as described in the 
Materials and Methods. RyR1 single channel in the absence of hemicalcin was used to serve as 
control and was recorded for 3 min (A). Sequential additions of hemicalcin to achieve a final 
concentration of 175 nM (B) and 350 nM (C) were made into cis chamber, and the channel 
Mis en forme : Exposant
Mis en forme : Exposant
Mis en forme : Indice
Mis en forme : Exposant
Mis en forme : Indice
Supprimé : 250 
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activity was recorded for 5 min under each condition. The dashed lines indicate the maximum 
current amplitude of the native RyR1 channel (37.2 pA) when the channel is fully open (o). The 
arrow indicating “c” shows the zero current level when the channel is in the fully closed state, 
and the arrow indicating “s” shows the hemicalcin-stabilized sub-conductance state of the 
channel. The terms of Po, τ
o
, τ
c
 and F
o
 represent open probability, mean open-dwell time, mean 
closed-dwell time and occurrence of stable sub-conductance in the total recorded period, 
respectively. The data is representative of a total of five independent bilayer experiments with 
RyR1 channels from one junctional SR protein preparation and one purified RyR1 preparation.  
 
Figure 6.  Homology model of hemicalcin 
Backbone ribbon representation of the model of hemicalcin and comparison with the structure of 
MCa (PDB code1C6W [11]), which, besides IpTx A, is one of the two structures used as 
template for molecular modelling. Disulfide bridges are in stick representation. Basic amino acid 
residues present on the same face of MCa and hemicalcin (K
19
, K
20
, K
22
, R
23
 ,R
24
 and K
30
) are 
shown. The side-chain bonds of K
11
/K
14
/D
13
/A
12 
in hemicalcin and K
11
/K
14
/N
13
/E
12
 in MCa are 
also shown. 
 
